Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut - Scorecard - MDSpire

Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut

  • By

  • Aleksandra Kopacz

  • Zuzanna Tomaszewska

  • Aleksandra Piechota-Polanczyk

  • June 24, 2026

  • 0 min

Share

Clinical Scorecard: The Interaction Between Estrogen Receptors and the NRF2 Pathway: Connecting Hormonal Control and Stress Response Mechanisms in the Intestinal System

At a Glance

CategoryDetail
ConditionEstrogen signaling and NRF2 interaction in the gastrointestinal system
Key MechanismsEstrogen receptors influence intestinal motility, barrier integrity, and nutrient absorption; NRF2 regulates cellular stress responses and detoxification.
Target PopulationIndividuals with gastrointestinal and metabolic disorders, with a focus on sex differences.
Care SettingClinical research and therapeutic strategy development.

Key Highlights

  • Estrogen signaling intersects with NRF2, suggesting a role in gut homeostasis.
  • Sex differences influence intestinal physiology and pathology, particularly in IBD.
  • NRF2 is a master regulator of the oxidative stress response, relevant in IBD.
  • Mouse models reveal sex-specific actions of NRF2 and estrogen signaling.
  • The microgenderome may contribute to estrogen–NRF2 crosstalk.

Guideline-Based Recommendations

Diagnosis

  • Consider sex-related differences in the incidence and presentation of gastrointestinal disorders.

Management

  • Explore estrogen receptor–NRF2 interactions for potential therapeutic strategies in gastrointestinal disorders.

Monitoring & Follow-up

  • Monitor oxidative stress levels and estrogen signaling in patients with IBD.

Risks

  • Inadequate understanding of sex differences may lead to gaps in treatment efficacy.

Patient & Prescribing Data

Patients with inflammatory bowel disease and related gastrointestinal disorders.

Estrogen signaling may modulate gut health and response to therapies.

Clinical Best Practices

  • Incorporate both male and female models in preclinical research to understand sex differences.
  • Assess the impact of hormonal fluctuations on gastrointestinal health in clinical settings.

Related Resources & Content

Original Source(s)

Related Content